Zobrazeno 1 - 10
of 11
pro vyhledávání: '"M J, Eskelinen"'
Autor:
J P, Böhm, L K, Niskanen, R T, Pirinen, K, Kiraly, J K, Kellokoski, K I, Moisio, M J, Eskelinen, H E, Tulla, S, Hollmen, E M, Alhava, V M, Kosma
Publikováno v:
The Journal of pathology. 192(3)
CD44 was detected with an antibody recognizing all forms of CD44 (CD44 standard) and others specific for its v3 and v6 variant isoforms; their prognostic value was evaluated in 213 patients with differentiated thyroid carcinoma (DTC). The staining pa
Autor:
P K, Auvinen, J J, Parkkinen, R T, Johansson, U M, Agren, R H, Tammi, M J, Eskelinen, V M, Kosma
Publikováno v:
International journal of cancer. 74(5)
Hyaluronan (HA) is one of the extracellular-matrix components involved in wound healing, tumour growth and metastasis. Due to the limited data on HA expression in benign and malignant breast lesions, we analyzed its presence in these lesions by using
Publikováno v:
The Journal of pathology. 182(3)
Clinical follow-up data of 276 colorectal adenocarcinoma patients treated in Kuopio University Hospital between 1976 and 1986 and followed up for a mean of 14 years were analysed. The clinical findings were correlated with tumour-infiltrating lymphoc
Autor:
P K, Lipponen, M J, Eskelinen
Publikováno v:
Anticancer research. 12(2)
The fraction of proliferating cells in 178 transitional cell carcinomas (TCCs) was determined by proliferating cell nuclear antigen (PCNA/cyclin) immunostaining. The fraction of positive nuclei ranged between 0% and 100%. In WHO grade 1 tumours only
Publikováno v:
International surgery. 76(4)
A prospective study on breast cancer was started in 1975, and ended in 1987 allowing a mean follow-up of 12.4 years. At the operation tumor size was registered, and after axillary evacuation axillary status was defined histologically. In 1989-1990 vo
Publikováno v:
Urology. 38(2)
The immunohistochemical detection of tumor marker CA 50 was studied in bladder cancer of WHO grades I-III. The material consisted of tumors in 83 patients and the mean clinical follow-up time was thirteen years (range 9.6-22 years). The fraction of C
Publikováno v:
Anticancer research. 11(2)
One hundred and eighty-seven patients with a transitional cell bladder cancer were followed by retrospectively for a mean of 9.5 years. Clinical stage (p less than 0.0001), histological grade (p less than 0.0001), papillary (p less than 0.0001), SPF
Autor:
P K, Lipponen, M J, Eskelinen
Publikováno v:
Anticancer research. 11(2)
The prognostic value of volume corrected mitotic index (M/V index) was improved in bladder cancer by correcting the M/V index for mean nuclear area (NA) in a section as an estimate of cellularity. The clinical follow-up data of 265 patients were obta
Autor:
P K, Lipponen, M J, Eskelinen
Publikováno v:
Anticancer research. 11(1)
Nucleolar organiser regions (NORs), which are related to regulation of protein synthesis and cell proliferation, were estimated subjectively in 89 bladder cancer patients by means of silver staining technique on archival paraffin sections. The number
Publikováno v:
European urology. 17(2)
A retrospective follow-up (range 9.4-22 years, mean 13 years) study of 83 patients with grade I-III (WHO) bladder carcinomas was performed. Nuclear area (mean +/- SD 59.7 +/- 18.7 microns2) and the SD of nuclear area (mean +/- SD 19.7 +/- 13.4 micron